The Peking University Alumni Association visited Yinfeng Biological Group
Release time:
2022-08-12
On August 12, a delegation composed of Peking University Alumni Association, Peking University Youth CEO Club and Peking University School of Innovation and Entrepreneurship visited Yinfeng Biological Group.
Wang Baoqing, President of Yinfeng Biological Group, Liu Guojun, Vice President of Yinfeng Biological Group and President of Qilu Stem Cell Company, and Zhang Guirong, Assistant to the President and Director of R&D Department of Yinfeng Biological Group, accompanied the visit.
The delegation visited the "Infinite Life Plan" Science Museum and the "Life Extension Plan" exhibition hall successively, and learned in detail about the storage and application prospects of cells in 5G scenarios, the application of cryogenic medicine, the first case of human cryopreservation in Asia, and the infinite possibilities of cryomedicine in organ transplantation and clinical applications. The delegation then visited the Shandong Provincial Cord Blood Bank and Yinfeng Gene Laboratory.
The inspection team conducted a comprehensive understanding of Yinfeng Biotechnology Group's industrial layout, cutting-edge technology, research and development innovation, and achievement transformation in the biomedical field. We highly recognize and praise the achievements of Yinfeng Biological Group.
Yinfeng Biotechnology Group is a high-tech enterprise driven by "cell+gene" dual engine innovation, specializing in the research and development, medical transformation, and clinical research of biomedical technologies such as human cell, tissue, and organ storage, gene sequencing technology, cell application technology, deep cryogenic medical technology, and health management services. After 19 years of deep cultivation, Yinfeng Biotechnology has taken the lead in connecting the entire human life cycle health management service industry chain nationwide, with the development vision of "becoming a leading domestic and world-class human life cycle health management service provider", and contributing Yinfeng's strength to serving "Healthy China"。
Previous article
Next article
Previous article
Next article
Latest developments
The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.
Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross
Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.
The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.
Public Welfare Partnership: A Special Letter from the Jinan Red Cross
On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).
World’s First Achievement Highlights Brand Leadership
In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.
Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference
Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155515
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
